FolioLanternBeta

Eikon Therapeutics, Inc. (EIKN)

Insiders reported no open-market sales in the past 12 months.

Latest filing: Filed Feb 10 for a conversion on Feb 6. Roger Perlmutter converted 285K shares between classes. Filing

See who sold, why, and what they still hold